Medicine and Dentistry
Colorectal Cancer
100%
Calgranulin
100%
Cardioversion
69%
Atrial Fibrillation
66%
Biological Marker
64%
False Negative Result
62%
Mass Screening
62%
Heart Failure
50%
Randomized Clinical Trial
50%
Disease Activity
50%
Rheumatoid Arthritis
50%
Endoscopy
50%
Heart Muscle Injury
50%
Methotrexate
50%
Meta-Analysis
50%
Hyperoxia
50%
Hyponatremia
50%
Prognostic Factor
50%
Non Small Cell Lung Cancer
50%
Systematic Review
50%
Colonoscopy
37%
Screening
25%
Overall Survival
25%
Copeptin
16%
C Reactive Protein
13%
Feces
12%
Laboratory Information System
12%
Division
12%
False Positive Result
12%
Personal Data
12%
Colorectal Cancer Screening
12%
Progression Free Survival
12%
Hazard Ratio
12%
Metabolomics
12%
Myocardial Infarction
12%
Blood Donor
11%
Disease Marker
9%
Atrial Flutter
8%
Troponin I
8%
Disorders of Calcium Metabolism
6%
Random Effects Model
6%
Malignant Neoplasm
6%
Checklist
6%
Small Cell Lung Cancer
6%
Cancer Types
6%
Natriuretic Peptide
5%
Peptide Analysis
5%
Nursing and Health Professions
Colorectal Cancer
100%
Biological Marker
64%
Hyperoxia
50%
Coagulometer
50%
International Normalized Ratio
50%
Meta Analysis
50%
Endoscopy
50%
Cardioversion
50%
Systematic Review
50%
Hyponatremia
50%
Non Small Cell Lung Cancer
50%
Calgranulin
50%
Heart Muscle Injury
50%
Primary Health Care
50%
Occult Blood Test
50%
General Practice
50%
Symptom
50%
Colonoscopy
37%
Outpatient Department
30%
Compliance
25%
Overall Survival
25%
Direct Current
20%
Enteropathy
18%
False Negative Result
18%
Atrial Fibrillation
16%
Copeptin
16%
Practice Guideline
12%
Cancer Screening
12%
Mass Screening
12%
Screening
12%
Malignant Neoplasm
12%
Personal Data
12%
Progression Free Survival
12%
Hazard Ratio
12%
Diagnosis
12%
Laboratory Device
10%
Capillary
10%
Prothrombin Time
10%
Warfarin
10%
Hospital Laboratory
10%
University Hospital
10%
Time Factor
10%
Heart Infarction
8%
Heart Atrium Flutter
8%
Troponin I
8%
Small Cell Lung Cancer
6%
Scopus
6%
Confidence Interval
6%
Electrolyte Disturbance
6%
Medline
6%
Checklist
6%
Embase
6%
Diagnostic Test
6%
Hemoglobins
6%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Rheumatoid Arthritis
100%
Methotrexate
100%
Brain Natriuretic Peptide
50%
Heart Failure
50%
Heart Muscle Injury
50%
Vitamin B12
50%
Pharmacokinetics
50%
Non Small Cell Lung Cancer
50%
Receptor
50%
Ciclosporin
50%
Calgranulin
50%
Hyponatremia
50%
Colorectal Cancer
50%
Disease Activity
50%
Warfarin
50%
Prothrombin
50%
Atrial Fibrillation
25%
Copeptin
25%
Transcobalamin
25%
Overall Survival
25%
Biological Marker
18%
C Reactive Protein
13%
Malignant Neoplasm
12%
Progression Free Survival
12%
Heart Infarction
12%
Troponin I
12%
Heart Atrium Flutter
12%
Disease Marker
9%
Prospective Study
8%
Adverse Event
7%
Pharmacokinetic Parameter
7%
Random Effects Model
6%
Small Cell Lung Cancer
6%
Electrolyte Disturbance
6%
Randomized Controlled Trial
5%